Clinical Trials Logo

Clinical Trial Summary

The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03328559
Study type Interventional
Source Groupe Hospitalier Paris Saint Joseph
Contact
Status Completed
Phase N/A
Start date March 7, 2016
Completion date August 20, 2021

See also
  Status Clinical Trial Phase
Completed NCT04802902 - Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting
Completed NCT04334239 - Effectiveness of Care in Certified Cancer Centres in Germany
Completed NCT03786653 - Feasibility of Immunotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting (ImHADom)
Recruiting NCT05886075 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors Early Phase 1
Completed NCT05027490 - CAncer, NUtrition and Taste 2 N/A
Not yet recruiting NCT02648087 - Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer N/A
Completed NCT05605236 - Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
Completed NCT03684486 - Rehabilitation by Effort for Patients With Advanced Bronchial Cancer N/A
Active, not recruiting NCT02877043 - Study of the Quality of Lung Resection N/A